Literature DB >> 25162660

AKT1 and AKT2 induce distinct phosphorylation patterns in HL-1 cardiac myocytes.

Michael Reinartz1, Annika Raupach, Wolfgang Kaisers, Axel Gödecke.   

Abstract

The protein kinase AKT is a central kinase in the heart and has a major impact on growth/hypertrophy, survival/apoptosis, and metabolism. To gain more insight into AKT isoform-specific signaling at the molecular level, we investigated the phosphoproteome of HL-1 cardiomyocytes carrying AKT1 or AKT2 isoform-specific knock down, respectively. We combined stable isotope labeling with high resolution mass spectrometry and identified 377 regulated phosphopeptides. Although AKT1 is expressed at 4-fold higher levels, insulin stimulation mainly activated AKT2, which might in part rely on a preferred interaction of AKT2 with the mammalian target of rapamycin complex 2. In line with this result, the highest number of regulated phosphopeptides was identified in the AKT2 knock down cells. Isoform-specific regulation of AKT targets not previously described could be observed, and specific regulation of indirect target sites allows a deeper insight into affected biological processes. In the myocardial context, we identified many phosphosites supporting a connection of AKT to excitation-contraction coupling. Phosphoproteins identified included L-type calcium channel, ryanodine receptor, junctophilin, histidine-rich calcium binding protein, phospholamban, heat shock protein beta-6, and Ca²⁺/calmodulin-dependent kinase II. In conclusion, AKT isoform-specific knock down combined with quantitative phosphoproteomics provided a powerful strategy to unravel AKT isoform-specific signaling.

Entities:  

Keywords:  AKT; cardiomyocytes; excitation−contraction coupling; insulin signaling; mass spectrometry; phosphoproteomics

Mesh:

Substances:

Year:  2014        PMID: 25162660     DOI: 10.1021/pr500131g

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  PI3K Isoforms in Vascular Biology, A Focus on the Vascular System-Immune Response Connection.

Authors:  Daniela Carnevale; Giuseppe Lembo; Sara Perrotta
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

2.  SH3BP4 promotes neuropilin-1 and α5-integrin endocytosis and is inhibited by Akt.

Authors:  Christoph J Burckhardt; John D Minna; Gaudenz Danuser
Journal:  Dev Cell       Date:  2021-03-23       Impact factor: 12.270

3.  Application of network pharmacology and molecular docking approach to explore active compounds and potential pharmacological mechanisms of Aconiti Lateralis Radix Praeparata and Lepidii Semen Descurainiae Semen for treatment of heart failure.

Authors:  Meng-Qi Yang; Cong Chen; Yi-Fei Mao; Yan Li; Xia Zhong; Yi-Ding Yu; Yi-Tao Xue; Yong-Mei Song
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

4.  Phosphoproteomic analysis identifies phospho-Threonine-17 site of phospholamban important in low molecular weight isoform of fibroblast growth factor 2-induced protection against post-ischemic cardiac dysfunction.

Authors:  Janet R Manning; Aruna B Wijeratne; Brian B Oloizia; Yu Zhang; Kenneth D Greis; Jo El J Schultz
Journal:  J Mol Cell Cardiol       Date:  2020-08-25       Impact factor: 5.000

5.  High-throughput screening and validation of antibodies against synaptic proteins to explore opioid signaling dynamics.

Authors:  Mariana Lemos Duarte; Nikita A Trimbake; Achla Gupta; Christine Tumanut; Xiaomin Fan; Catherine Woods; Akila Ram; Ivone Gomes; Erin N Bobeck; Deborah Schechtman; Lakshmi A Devi
Journal:  Commun Biol       Date:  2021-02-22

6.  Consistency of biological networks inferred from microarray and sequencing data.

Authors:  Veronica Vinciotti; Ernst C Wit; Rick Jansen; Eco J C N de Geus; Brenda W J H Penninx; Dorret I Boomsma; Peter A C 't Hoen
Journal:  BMC Bioinformatics       Date:  2016-06-24       Impact factor: 3.169

7.  Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function.

Authors:  Thorsten Hartmann; Sabrina Overhagen; D Margriet Ouwens; Silja Raschke; Paulus Wohlfart; Norbert Tennagels; Nina Wronkowitz; Jürgen Eckel
Journal:  Cardiovasc Diabetol       Date:  2016-07-15       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.